Search Results - "Yiannopoulos, Georgios"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
  2. 2
  3. 3

    B-Cell Depletion Therapy in Systemic Sclerosis: Experimental Rationale and Update on Clinical Evidence by Andonopoulos, Andrew P., Yiannopoulos, Georgios, Liossis, Stamatis-Nick C., Daoussis, Dimitrios

    Published in International Journal of Rheumatology (01-01-2011)
    “…Systemic sclerosis (SSc) is a systemic rheumatic disease with poor prognosis since therapeutic options are limited. Recent evidence from animal models suggests…”
    Get full text
    Journal Article
  4. 4

    Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study by Daoussis, Dimitrios, Liossis, Stamatis-Nick C., Tsamandas, Athanassios C., Kalogeropoulou, Christina, Kazantzi, Alexandra, Sirinian, Chaido, Karampetsou, Maria, Yiannopoulos, Georgios, Andonopoulos, Andrew P.

    Published in Rheumatology (Oxford, England) (01-02-2010)
    “…Objective. To assess the efficacy of rituximab (RTX) in SSc. Methods. Fourteen patients with SSc were evaluated. Eight patients were randomized to receive two…”
    Get full text
    Journal Article
  5. 5
  6. 6

    ACTH as first line treatment for acute gout in 181 hospitalized patients by Daoussis, Dimitrios, Antonopoulos, Ioannis, Yiannopoulos, Georgios, Andonopoulos, Andrew P

    Published in Joint, bone, spine : revue du rhumatisme (01-05-2013)
    “…Abstract Objective We aimed at assessing the efficacy and safety of adrenocorticotropic hormone (ACTH) for the treatment of acute gout in hospitalized…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Evolution of undifferentiated arthritis: a ten-year experience from the early arthritis clinic of a tertiary care hospital by Yiannopoulos, Georgios, Daoussis, Dimitrios, Melissaropoulos, Konstantinos, Tsouni, Christina, Andonopoulos, Andrew P

    Published in Clinical and experimental rheumatology (01-05-2015)
    “…Undifferentiated arthritis (UA) is an inflammatory oligo/polyarthritis where no definite diagnosis can be reached. Patients with UA may progress towards a…”
    Get full text
    Journal Article
  10. 10
  11. 11

    L’ACTH comme traitement de première intention dans la goutte aiguë chez 181 patients hospitalisés by Daoussis, Dimitrios, Antonopoulos, Ioannis, Yiannopoulos, Georgios, Andonopoulos, Andrew P.

    “…Nous avons évalué l’efficacité et la tolérance de l’hormone adrénocorticotrope (ACTH) dans le traitement de la crise de goutte chez des patients hospitalisés…”
    Get full text
    Journal Article
  12. 12

    Evidence that Dkk‐1 is dysfunctional in ankylosing spondylitis by Daoussis, Dimitrios, Liossis, Stamatis‐Nick C., Solomou, Elena E., Tsanaktsi, Anastasia, Bounia, Konstadina, Karampetsou, Maria, Yiannopoulos, Georgios, Andonopoulos, Andrew P.

    Published in Arthritis and rheumatism (01-01-2010)
    “…Objective Dkk‐1 is an inhibitory molecule that regulates the Wnt pathway, which controls osteoblastogenesis. This study was undertaken to explore the potential…”
    Get full text
    Journal Article
  13. 13
  14. 14